Your comment is well taken on the Canadian dollar. One of the pre-eminent sales messages we've had as an industry internationally is that the cost of doing business here has been incredibly efficient. We're now, as an industry, having a look at where in fact we will start to see the impact first. It's still a little nascent right now, because a lot of those relationships were long-term contracts. The question will be, very immediately, is it still cheap to do business with you folks up here?
We're not sure exactly where that's going to fall immediately. Certainly things such as clinical trial operations and that sort of thing would probably be impacted first.
There's no doubt there will be an impact. How deep it will be over the long term is still be to assessed.